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ABSTRACT: Bioorthogonal correlative light-electron microscopy (B-
CLEM) can give a detailed overview of multicomponent biological
systems. It can provide information on the ultrastructural context of
bioorthogonal handles and other fluorescent signals, as well as
information about subcellular organization. We have here applied B-
CLEM to the study of the intracellular pathogen Mycobacterium
tuberculosis (Mtb) by generating a triply labeled Mtb through combined
metabolic labeling of the cell wall and the proteome of a DsRed-
expressing Mtb strain. Study of this pathogen in a B-CLEM setting was
used to provide information about the intracellular distribution of the
pathogen, as well as its in situ response to various clinical antibiotics,
supported by flow cytometric analysis of the bacteria, after recovery
from the host cell (ex cellula). The RNA polymerase-targeting drug
rifampicin displayed the most prominent effect on subcellular distribution, suggesting the most direct effect on pathogenicity and/or
viability, while the cell wall synthesis-targeting drugs isoniazid and ethambutol effectively rescued bacterial division-induced loss of
metabolic labels. The three drugs combined did not give a more pronounced effect but rather an intermediate response, whereas
gentamicin displayed a surprisingly strong additive effect on subcellular distribution.
■ INTRODUCTION
Mycobacterium tuberculosis (Mtb), the causative agent of
tuberculosis (TB), is currently the deadliest pathogen in the
world. It is responsible for approximately 10 million cases and
1.6 million deaths every year.1 Moreover, a quarter of the
world’s population is estimated to be carrying the latent form
of the disease.1 All this has become even more urgent over the
last few decades with multidrug resistant (MDR-) and
extensive drug resistant (XDR-) variants becoming increasingly
prevalent.1 Vaccine and drug development for Mtb has proven
to be slow and challenging, in part due to the highly complex
pathogen−host interactions and lack of suitable antigens.2,3
The intracellular lifecycle ofMtb further affects this problem.
Upon infection of host cell macrophages, its behavior is highly
heterogeneous: both fast- and slow-growing forms of the
bacteria exist,4,5 the latter displaying tolerance to most
drugs.6−12 This has resulted in the requirement for long
treatment periods with cocktails of antibiotics, with the current
standard of care being a six to nine-month course of rifampicin,
isoniazid, ethambutol, and/or pyrazinamide.13 Treatment of
MDR-TB requires more extensive antibiotic treatment, lasting
up to 2 years, with poor side-effect profiles.14 Recently, a new
therapy for MDR-TB and XDR-TB was approved consisting of
pretomanid in combination with bedaquiline and linezolid, and
several others are currently under clinical development.13
Mtb is a facultative intracellular pathogen that primarily
colonizes the lungs of patients by entering the upper and lower
airways, through aerosol-transfer.15 At these sites, Mtb is
phagocytosed by alveolar macrophages, whichrather than
clearing the pathogenserve as their host cells.16 The
longstanding coevolution of Mtb with humans has resulted in
the emergence of many mechanisms by which Mtb can
interfere with the cellular and organismal immune responses.17
It can, for example, inhibit phagosome acidification, block the
recruitment of EEA1 and interfere with the Rab5-to-Rab7
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conversion,18 resulting in the formation of a nutrient rich
compartment that favors survival and replication of the
pathogen.18,19 Mtb is also able to inhibit autophagy and
apoptosis, effectively blocking all of the backup mechanisms for
microbial killing.20,21 Even if maturation of the phagosome
does occur, Mtb is known to be strongly resistant to both
acidic conditions (down to pH 4.5) and the reactive oxygen
and nitrogen species (ROS/RNS) normally employed to kill
phagosomal pathogens by virtue of its thick cell wall,21 the
production of antioxidative mycothiol (MSH),21 and several
neutralizing enzymes.20,21
It has recently been shown that the localization of Mtb
within the cell is also a complex and highly dynamic process:
some phagosomes are arrested in an early state, while the
majority of phagosomes will follow the conventional
maturation pathway, or a Rab20-dependent pathway to form
a spacious phagosome.22 Damaging of the phagosome allows
the bacterium to avoid degradation or even escape to the
cytosol, followed by rapid replication and host cell necrosis.23
Recapture of the cytosolic bacteria may occur through
ubiquitin-mediated autophagy, which again may lead to
autophagosome maturation or arrest.24−26 The precise
contribution of these stages to overall Mtb survival is not yet
known, nor is the change in this dynamic during drug
treatment known; however, it implicates a dynamic host−
pathogen “arms race”. Even if a successful immune response
usually supported by T-cell helpis mounted against Mtb,
generally a subpopulation of so-called “persister cells” remain
in a dormant state. These bacteria have downregulated
metabolic activity, upregulated stress-related genes, and as a
result can establish a drug-tolerant, latent infection.7
This complex intracellular life cycle has made the study of
Mtb difficult. Development of imaging techniques that allow
the identification and study of the various stages of intracellular
survival or killing of Mtb has been long sought after.
Fluorescent protein-modified Mtb has allowed its imaging by
confocal microscopy, but the reliability of fluorescent proteins
varies and the fluorescence is lost upon degradation of the
protein by the host.27 Metabolic labeling of the mycobacterial
cell wall, using fluorescent or bioorthogonal analogues of D-
alanine28,29 or trehalose,30−32 or using fluorescent antibiotic
analogues has allowed the study of growing and dividing
Mtb.33−35 This has, for example, allowed the discrimination of
live from dead Mtb in sputum samples.32 Finally, a dual-
targeting activity-based probe was recently reported, combin-
ing the activity of two Mtb-specific enzymes to obtain
extremely high specificity for Mtb over other mycobacteria.36
These approaches are, however, all based on fluorescent
techniques. Thisin view of the complex life cycle of Mtb in
the hostlacks information on, for example, host compart-
ments and other ultrastructural features during infection.
Electron microscopy (EM) provides ultrastructural informa-
tion but has limited options for labeling specific components of
the bacterium and host, compared to fluorescent labeling
techniques. For the study of Mtb, EM has proven useful to
delineate parts of its life cycle, such as phagosome maturation,
perturbation and repair, as well as cytosolic entry and reuptake
by autophagy.22,25,37−39 Correlative techniques, in which light
and electron microscopy are combined, have proven to be
powerful by providing both structural and functional
information in one multimodal data set, that can be visualized
in a single image. The combination of fluorescence microscopy
and transmission electron microscopy (TEM) is known as
correlative light-electron microscopy (CLEM).40 For the study
of Mtb, CLEM has been used to show Mtb replication within
necrotic macrophages,41 to discover a previously unknown
niche for Mtb replication in the lymph nodes of TB patients,42
and to visualize the subcellular distribution of bedaquiline in
Mtb-infected macrophages.43
In order to combine the information that metabolic labeling
studies can provide on the intracellular life cycle of Mtb with
the information on bacterial structure and host cell biology
that CLEM can provide, we decided to combine the two
approaches. We have previously shown that the intracellular
proteome labeled with alkyne or azide-containing amino acids
can be selectively visualized by B-CLEM within a mammalian
host cell (including degradation products stemming from the
phagocytosed bacteria).44,45 However, this only provided one
parameter to study. We reasoned that, in order to provide a
useful imaging approach for intracellular Mtb, multiple
parameters relating to the intracellular lifecycle of the bacillus
had to be visualized in parallel.
We here explore the option of combining two bioorthogonal
labels in parallelone for labeling the proteome and one for
labeling the peptidoglycan layeras well as the expression of a
fluorescent protein. These three parameters, in combination
with ultrastructural information, can yield information on
where the bacteria are localized intracellularly, whether the
bacteria are dividing, and to what extent antimycobacterials
exert their antimicrobial effects. We describe a pathogen
labeled with L-azidohomoalanine (Aha; proteome labeling),
alkynyl-D-alanine (alkDala; peptidoglycan labeling), and
DsRed (anabolic activity) and study its fate inside a
macrophage cell line. Using dual copper-catalyzed Huisgen
(ccHc) “click” labeling on thin sections, we could study these
three parameters in their ultrastructural context. The two
handles could be consecutively reacted without apparent cross-
reactivity between handles (no loss of signal or altered patterns
were observed compared to single labels). This B-CLEM
approach allowed us to examine the intracellular distribution of
the bacterium and link this information to the retention of the
metabolic labels over time. Comparing these parameters
between untreated cells and cells treated with rifampicin,
isoniazid, ethambutol, or a combination of the three provided
valuable insights into the subcellular effect of these clinical
antibiotics. These observations were then further substantiated
using a flow cytometry-based assay that allowed a more
thorough quantification of the label retention under these
conditions.
■ RESULTS AND DISCUSSION
Production and Validation of Triple-Label Mtb. We
have previously optimized the incorporation of bioorthogonal
amino acids in E. coli and S. enterica serovar Typhimurium,
based on the BONCAT-protocol developed by the Tirrell-
lab.46−49 Using in-gel fluorescence after ccHc of bacterial
lysates, label incorporation into the bacterial proteome could
be quantified on the population level. Flow cytometry of fixed
bacteria allowed the quantification of the label on a per-
bacterium level.44,45 These studies have yielded optimal
labeling conditions consisting of a pulse with the bioorthog-
onal amino acid (4 mM) for approximately 1−2 doubling
times (30 min in case of the above species). Whereas increased
incubation led to reduced growth and viability.44,45
In order to optimize bioorthogonal amino acid-incorpo-
ration into the Mtb-proteome, we first optimized the lysis
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conditions forMtb to maximize protein recovery (and killing of
the pathogen to allow handling outside the ML-III facility).
This was achieved with a combination of 1% SDS and heat
treatment, as we noticed that detergents alone were insufficient
for both killing and protein recovery (Table S1). We used
these lysis conditions to assess bioorthogonal amino acid
incorporation. As the generation time of Mtb is approximately
24 h, we began exploring conditions starting from 4 mM
azidohomoalanine (Aha) or homopropargylglycine (Hpg) for
48 h. We found that the label incorporation plateaued around
48 h but that labeling times >48 h reduced cell growth,
particularly for homopropargylglycine-treated cells (Figure
1A). We therefore chose to focus on Aha for proteome
labeling.
Cell wall labeling conditions with alkynyl-D-alanine
(alkDala), a ccHc-reactive precursor in the cell wall synthesis,
were taken from Siegrist et al., 2013.28 Single labeling
experiments with Aha or alkDala showed that no detrimental
effects on viability were observed up to 48 h for either label in
terms of viability (Figure 1A). Even extensively labeled Mtb
(144 h) seemed to recover their growth rate after medium
exchange (Figure S1). We next determined whether this was
also the case for dual labeling with Aha and alkDala (Figure
1A, Figure S1). Coincubation of Mtb with both labels did not
enhance toxicity up to the 48 h time point and revealed
homogeneous proteome labeling (Figure 1B). From the gel-
based incorporation assay, we concluded that treatment of Mtb
for 48 h with both labels gave the optimal labeling (combined
with the most facile protocol).
We next wanted to determine whether all cells incorporated
the label to an equal extent in a flow cytometry-based assay.
Again, previous protocols for bacterial fixation and permeabi-
lization for flow cytometry were found to be incompatible with
ccHc on Mtb. This was likely due to the thick (40−100 nm)
and highly complex mycobacterial cell wall.51 The mycobacte-
rial cell wall contains multiple layers of (peptido)glycans and
lipids, including the ultralipophilic mycolic acids that can be up
to 90 carbons in length.52 In practice, this results in
hydrophobic aggregation of bacteria (especially after fixation)
and an impermeability to the ccHc-reactive fluorophores. We
postulated this would reduce the yields of the two ccHc-
reactions. We explored a wide range of permeabilization
conditions, varying detergents, permeabilization, and fixation
conditions (Table S2). After this extensive optimization, it was
found that the most effective conditions for permeabilizing the
bacteria for flow cytometric analysisthat balanced the
permeability with the structural integrity required to remain
intact during ccHc reactionwere pretreatment with 1% SDS
for 15 min, followed by overnight fixation with 4%
paraformaldehyde at room temperature (Table S2). Addition
of BSA as an anticlumping additive during staining steps
(Table S3) was needed to avoid hydrophobic aggregation of
the fixed bacteria.
Despite this extensive set of optimization experiments, a
subpopulation of DsRed positive events (∼25%) remained
unlabeled by both click reactions, perhaps due to them being
dead before labeling, permeabilization resistant, or metabol-
ically inactive.7,53 They were excluded from quantification by
gating for the double positive (Aha+/alkDala+) quadrant
(Figure 2A, Figure S2). It was also shown that preincubation
with Rifampicin for 1 and 24 h respectively reduced or
abolished Aha-incorporation at 0.1, 1.0, and 10 μg/mL (Figure
S3). The cell wall inhibitor D-cycloserine achieved the same
for alkDala incorporation (Figure S4). Heat killing (Figure
S5B) or paraformaldehyde fixation (Figure S5C) abolished the
incorporation of both labels. With these restrictions applied,
label incorporation for Aha and alkDala seemed to follow a
similar trend as observed for the SDS-PAGE assay.
Incorporation of both labels plateaued at 48 h incubation,
with high signal-to-background (Figure 2A-viii).
Bioorthogonal CLEM as a Multiparameter Analysis
Method to Study Intracellular Mtb. After successfully
constructing triple label Mtb, their compatibility with our
previously reported bioorthogonal CLEM method was
assessed (Figure 2B, Figure 3). To this end, DsRed-expressing
Mtb were incubated with Aha (4 mM) and alkDala (5 mM)
simultaneously for 48 h for maximum label incorporation. The
bacteria were prepared for cryo-sectioning, according to the
Tokuyasu method.54−56 Briefly, samples were fixed with
paraformaldehyde and glutaraldehyde (2% w/v and 0.2% w/
v respectively for 2 h), after which the bacterial pellet was
rinsed with PBS and embedded in 12% gelatin. Millimeter-
Figure 1. Production and validation of triple label Mtb. DsRed-expressing Mtb H37Rv were incubated with 4 mM Hpg, 4 mM Aha, 5 mM alkDala
or a combination of 4 mM Aha and 5 mM alkDala (dual), for the indicated time in Middlebrook 7H9 broth. (A) Bacterial viability during label
incorporation was assessed by normalizing the growth rate (OD600 measurements) to control bacteria, grown in the absence of metabolic labels.
The number of biological replicates for each OD600 measurement is indicated above the bar; error bars indicate standard deviation from the mean.
(B) Label incorporation throughout the proteome was analyzed by in-gel fluorescence, following bacterial lysis, ccHc reaction with AF647-azide
(alkDala/Hpg) or AF647-alkyne (Aha/dual) and SDS-PAGE. Coomassie Brilliant Blue staining was used as a loading control; shown as an insert
around the most prominent 60 kDa band, resulting from the DsRed-expression plasmid containing the Hsp60 promotor.50
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sized cubes were prepared manually, followed by sucrose
infiltration and plunge-freezing on sample pins. Ultrathin
cryosections (75 nm) were prepared and transferred to a
Formvar/carbon-coated titanium TEM-grid. Thawed cryo-
sections were subjected to on section click-reaction with
AF647-azide or AF647-alkyne for equal comparison between
Aha and alkDala incorporation. Using these experiments, the
label incorporations could be confirmed (with the sectioning
being used in lieu of permeabilization). Both alkDala and Aha
were minimally detectable after 1 h with the signal increasing
upon longer incubation (Figure 2B). Optimal label incorpo-
ration is observed after 48 h without any noticeable effect on
DsRed fluorescence. No detectable background fluorescence
was observed for the unlabeled control samples (Figure S6).
Next, these single bacteria were imaged by B-CLEM: Fresh
sections were prepared and subjected to double on-section
click-reaction with AF647-azide and AF488-alkyne, with
washing in between. The labeled sections were first imaged
in the confocal microscope, then stained with uranyl acetate
and imaged by TEM. The resulting images were then
correlated using Photoshop to obtain the final CLEM images
(Figure 3, Figure S7). These CLEM images show that >80% (n
= 200) of bacteria were positive for alkDala, Aha and/or
DsRed, suggesting suboptimal permeabilization was respon-
sible for the incomplete labeling observed by flow cytometry
above. The proteome label Aha colocalized largely with the
fluorescent protein DsRed.
To explore the possibility of studying intracellular Mtb
localization and processing, we next infected a murine (LPS-
Figure 2. Optimization of label incorporation. DsRed-expressing Mtb H37Rv were incubated with 4 mM Aha, 5 mM alkDala or a combination of 4
mM Aha and 5 mM alkDala (dual), for the indicated time in Middlebrook 7H9 broth. (A) Label incorporation per bacterium was quantified by
flow cytometry after sequential ccHc reaction with AF647-azide (alkDala) and AF488-alkyne (Aha) on fixed and permeabilized bacteria. Bacteria
were selected based on size (gate 1), shape (gate 2), fluorescence (gate 3), and exclusion of extreme outliers (gate 4). Quantification of the label
incorporation was achieved by selecting the median fluorescence intensity (MFI) of the major [Aha+/alkDala+] population for dually labeled Mtb
or the major [Aha-/alkDala-] population for unlabeledMtb. Controls and normalized MFI values are shown in Figure S2. (B) Triple labelMtb were
processed for cryo-sectioning, followed by ccHc reaction with AF647-azide (alkDala) or AF647-alkyne (Aha), to confirm the increase in label
incorporation over time on ultrathin sections that can be directly used for CLEM. All scale bars represent 5 μm.
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stimulated) macrophage cell line (RAW 264.7)57,58 with the
double labeled DsRed-positive Mtb (MOI 25). We wanted to
explore whether signs of viability could be extrapolated from
the information-dense CLEM images, containing both the
ultrastructural information on EM and the functional
information on the multilabel fluorescence microscopy. After
Tokuyasu sample preparation, we were able to obtain large
field of view CLEM images containing over 100 cell-profiles
per image at 11 000× magnification by applying an in-house
developed EM-stitching algorithm.59 This approach provides a
large data set for qualitative and quantitative analysis of EM
structures, guided by the fluorescence (illustrated in Figure
S8). As observed in previous EM studies,19,60 the mycobacte-
rial cell wall shows a typical electron translucent layer,
representing the mycomembrane (MM), enclosed by an
electron-dense outer layer (OL) and the peptidoglycan layer
(PGL) (Figure 4i). The bacterial cell wall is delineated by the
signal distribution of alkDala (Figure 4iv). Mtb was found to
be spread over different compartments, such as small or tight
vacuoles (Figure 4v, Figure S9B), large or spacious vacuoles
(Figure 4ix, Figure S9C), or what appeared to be non-
membrane-bound compartments (which could be due an
insufficient membrane preservation on EM) (Figure 4i, Figure
S9A). The presence of Mtb in these apparently nonmembrane-
bound compartments suggests escape from the parasitic
vacuole to the cytosol, as been reported in multiple
studies.19,23,61−64 In some cases, a double membrane was
observed in proximity of an apparently cytosolic bacterium
(Figures S8D and S9A-iv), which is a hallmark of autophagy,65
implying that this process may occur.
At 24 h postinfection, 23% of bacteria were found in small
vacuoles, 72% in large vacuoles, and 5% with no detectable
membrane (n > 500 bacteria counted). Additionally, a small
percentage of bacteria (<5% of total) was found extracellularly,
surrounded by cell debris (illustrated in Figure S10A,B). Many
large vacuoles contained both bacteria and cell debris,
suggesting the bacteria could have escaped from the previous
host cell,23,66 before reuptake by another macrophage (Figure
S10B). If host cell necrosis occurs, the plasma membrane
integrity is lost, causing the cell to fall apart, which allows the
bacteria to escape. However, if the host cell initiates apoptosis,
the entire cell including bacteria can be taken up by a
neighboring macrophage in a process called efferocytosis.67
Distributions of bacteria indicative for either secondary
phagocytosis of Mtb, following necrosis of the host cell
(Figure S10C-i) or efferocytosis, when the entire apoptotic cell
is internalized (Figure S10C-ii), were observed.
Bioorthogonal CLEM of Mtb-infected macrophages reveals
the effect of antibiotics on the bacterial integrity and
intracellular processing. To determine how the intracellular
distribution and fluorescent signals of triple label Mtb would
be affected by the commonly used antibiotics used in the
treatment of tuberculosis, we repeated the experiment in the
presence of rifampicin, isoniazid, ethambutol, or a combination
of the three for 24 h. All drugs except ethambutol alone
induced a significant alteration in the intracellular distribution
of the bacteria (Figure 5A), with the triple-antibiotic cocktail
showing the most pronounced effect, with 15% of bacteria
residing in small vacuoles, 84% in large vacuoles, and only 1%
did not appear to be within a vacuole (n > 500). Interestingly,
when cells were incubated with heat-killed bacteria, 95% of all
bacteria were found in large vacuoles, with <0.5% present in
structures without a detectable membrane. The individual
drugs had less pronounced effects on distribution (Figure 5A).
Rifampicin caused the largest shift in subcellular localization,
with 12% of bacteria residing in small vacuoles, 85% in large
vacuoles, and 3% not within a vacuole (n > 500). Isoniazid had
a less pronounced effect, with 20% of bacteria in small
Figure 3. Bioorthogonal CLEM of triple label Mtb in vitro. Triple label Mtb were processed for cryo-sectioning, followed by sequential ccHc
reaction with AF647-azide and AF488-alkyne. The fluorescently labeled sections were imaged by confocal microscopy, followed by TEM and the
images were correlated to obtain the CLEM image. The lower panel shows details from the large field of view CLEM image presented in Figure S4.
The top panel shows the corresponding fluorescence channels separately for clarity. All scale bars represent 1 μm.
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vacuoles, 78% in large vacuoles, and 3% not within a vacuole (n
> 500). Ethambutol did not show a significant difference
compared to the control.
A large percentage of bacteria were found to be extracellular
upon treatment with isoniazid (41% of total, n > 500) or
ethambutol (12% of total, n > 500; Figure S11A), suggesting
different drug mechanisms of action are involved. In addition,
isoniazid treatment appeared to increase the occurrence of
apparent host cell death (37%, n > 500), while ethambutol
appeared to decrease host cell death (2%, n > 500; Figure
S11B). These findings prompted us to reconsider our standard
infection protocol, in which the infected cells are coincubated
with a low concentration of gentamicin (5 μg/mL) to kill off
extracellular bacteria. We hypothesized that during the 24 h of
incubation, many bacteria could escape from the host cell and
be affected by the extracellular gentamicin, before being taken
up by another macrophage. This may result in an artificially
high number of dead bacteria, leading to skewing in the relative
intracellular subpopulations. To test this, Mtb-infected cells
were incubated with or without the triple-antibiotic cocktail, in
the presence or absence of gentamicin, for 24 h and processed
for CLEM. Indeed, a significant effect on the intracellular
distribution was observed for both the triple-antibiotic cocktail
and the untreated cells, when comparing the presence or
absence of gentamicin (Figure 5B). Interestingly, a similar
effect can be observed when comparing the triple-antibiotic
cocktail to the control, either with gentamycin or without. This
implies an additive drug effect for gentamicin, on top of the
other antibiotics. Indeed, Mtb-infected cells in the complete
absence of antibiotics showed only 50% of the bacteria residing
in large vacuoles versus 31% in small vacuoles and 19% without
an apparent vacuole (n > 500). Gentamicin was therefore
excluded from all further experiments.
In addition to the intracellular distribution of Mtb, the shape
of the bacterial profile appeared to be affected by the
antibiotics as well. After (cryo-)sectioning of the rod-shaped
Figure 4. Bioorthogonal CLEM of triple label Mtb in RAW 264.7 macrophages. Triple label Mtb were processed for cryo-sectioning, followed by
sequential ccHc reaction with AF647-azide and AF488-alkyne, and counterstaining with DAPI. Fluorescently labeled sections were imaged by
confocal microscopy, followed by TEM and the images were correlated to obtain the CLEM image. The fuzziness of the fluorescent signal is a
result of the difference in resolution between the techniques as governed by the Abbe-limit of diffraction. Representative examples of intracellular
triple label Mtb are shown, not within a vacuole (i−iv), in a small/tight vacuole (v−viii), or in a large/spacious vacuole (ix−xii). Small field of view
CLEM images with separated fluorescence channels are shown for clarity. Corresponding large field of view image is presented in Figure S5. N =
nucleus, M = mitochondria, PGL = peptidoglycan layer, MM = mycomembrane, OL = outer layer. A dotted line indicates the apparent vacuole
where relevant. All scale bars represent 1 μm.
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Mtb, the expected bacterial profile is somewhere between
circular and elongated, but always ovaloid in shape (Figure 5C-
i). Indeed the bacterial profiles after 24 h of intracellular
incubation without antibiotics were primarily ovaloid in shape
(69%, n > 500; Figure S13D). The remaining bacterial profiles
display an irregular “pointy” shape (Figure 5C-ii/iii/S13B),
perhaps suggesting a loss of bacterial integrity prior to fixation.
Triple antibiotics treatment appeared to increase the number
of irregular profiles (57%, n > 500; Figure S13D), which may
indicate an increase in Mtb killing. Some vacuoles were even
Figure 5. Effect of different antibiotics on the intracellular distribution and shape of triple label Mtb in RAW 264.7 macrophages. (A) Intracellular
distribution of Mtb was manually classified as not within a vacuole (none), small/tight vacuole (small) or large/spacious vacuole (large), after 24 h
of incubation with rifampicin (RIF), isoniazid (INH), ethambutol (EMB), triple antibiotics cocktail (triple), or without antibiotics (control).
Shown as percentage relative to total number of intracellular Mtb counted in the analyzed region; n > 500 for all. (B) The additional effect of
gentamicin (GEN) on the intracellular distribution of Mtb was assessed after 24 h of incubation with triple antibiotic cocktail (triple ±GEN) or
without antibiotics (control ±GEN). Raw distributions were pairwise compared using the chi-square test and corrected for multiple testing using
the Benjamini−Hochberg procedure, with a false discovery rate (FDR) of 0.1 (****: p < 0.0001, **: p < 0.01, *: p < 0.05, ns: not significant). (C)
Zoom-in CLEM examples of the most common shapes, observed for bacterial profiles, classified as ovaloid (i), irregular (ii/iii), or no recognizable
structure (iv; enhanced contrast of fluorescence for visual purposes). Relevant structures are indicated with an asterisk (*). A dotted line indicates
the apparent vacuole where relevant. All scale bars represent 1 μm.
Figure 6. Quantification of label retention after intracellular incubation of triple labelMtb in RAW 264.7 macrophages with antibiotics. (A) CLEM-
based semiautomatic quantification of label retention after 24 h intracellular incubation with triple antibiotics cocktail (triple) or without antibiotics
(control). Distribution of the mean fluorescence intensity per bacterial profile (n = 200). Thick horizontal line represents population mean, thin
horizontal lines represent standard deviation (***: p < 0.001, ns: not significant, Mann−Whitney U test). (B) Flow cytometry-based quantification
of label retention ex cellula, after 24 h intracellular incubation with rifampicin (RIF), isoniazid (INH), ethambutol (EMB), triple antibiotic
treatment (triple) or without antibiotics (24h control), normalized on bacteria recovered immediately after infection (0 h control). Corresponding
dot plots and MFI values, before normalization, are shown in Figure S12.
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found to contain distinct fluorescence while entirely lacking
any recognizable bacterial structure (Figure 5C-iv, Figure
S13C), potentially carrying degradation products of the labeled
Mtb. Interestingly, heat-killed bacteria were predominantly
observed as irregular shapes (95%, n > 500; Figure S13D) but
with a well-preserved cell wall.
The early intracellular population of Mtb, immediately after
infection, was highly concentrated in large vacuoles (>80%, n >
200). At this time point (0h postinfection), no significant effect
of antibiotic pretreatment (24 h triple-antibiotic cocktail in
vitro, before infection) on the subcellular distribution (Figure
S12A) nor on the bacterial profiles of Mtb (Figure S13F) was
observed, suggesting that more time is required for processing
of the bacteria by the host cell. The untreated bacteria do
appear to reside more in large clusters of smaller vacuoles,
while the pretreated bacteria were mostly found in large and
spacious vacuoles (see Figure S12B for examples). However,
this classification criterium was too subtle for unbiased manual
quantification.
CLEM and Flow Cytometry-Based Quantification of
Mtb Label Retention upon Antibiotic Treatment. The
average fluorescence intensity, resulting from the metabolic
labels Aha and alkDala, can be used as a measure for bacterial
division, as the label content per bacterium will “dilute” upon
division. We were able to quantify the average fluorescence
intensity per bacterium-profile from the images. First the
bacteria were segmented, and the mean fluorescence intensity
(MFI) was analyzed for each of the three fluorescence
channels (n > 200 bacteria analyzed). DsRed-negative bacteria
were excluded from analysis. These results show that
intracellular Mtb, treated with the triple-antibiotic cocktail,
retain more Aha and lose DsRed compared to the untreated
control (Figure 6A, Figure S14). No significant difference in
alkDala retention was observed (Figure 6B), although analysis
artifacts due to the spreading of alkDala fluorescence beyond
the selected bacterial outline (Figure S14), as well as variations
in section thickness, cannot be excluded.
Since quantification of CLEM is intrinsically limited by its
laborious correlation procedure, we set out to develop an
additional method for quantifying the effect of antibiotics on
bacterial proliferation that could support the observations done
in CLEM. We therefore set up a method to analyze the
bacteria by flow cytometry after recovery from the infected
host cells (ex cellula). This was achieved by selective host cell
lysis (adapted from Liu et al. 2015),68 followed by fixation and
click labeling of the recovered bacteria, using the method
described above, to obtain optimal signal-to-noise and optimal
recovery of bacteria.
The cytometry results show a clear loss of Aha and alkDala
retention per bacterium over time (24 h vs 0 h control), in the
absence of antibiotics (Figure 6B, Figure S15). This loss was
largely avoided by isoniazid and ethambutol. Heat-killed
bacteria showed no loss of label over time (Figure S16J).
Rifampicin does not show an effect on label retention,
suggesting a different mechanism of action (Figure 6B, Figure
S15, Figure S16). The triple-antibiotic cocktail showed an
intermediate effect on label retention, suggesting a combina-
torial but nonadditive effect on label retention. No significant
effect on DsRed was observed for any of the antibiotics,
through this quantification approach. However, isoniazid and
ethambutol show a distinct reduction in the typical Mtb
autofluorescence,69 similar but to a smaller degree as heat-
killed Mtb (Figure S16F). This reduction in autofluorescence
has previously been suggested as an indication for
mycobacterial viability.70
Taken together, our results indicate thatwithin the context
of our LPS-stimulated murine macrophage infection system
rifampicin mostly affects Mtb pathogenicity, while isoniazid
and ethambutol seem to affect Mtb division more directly;
although the complexity and heterogeneity of the life cycle of
Mtb in host cells remains profound.
■ CONCLUSIONS
We describe a combinatorial method for studying the
intracellular localization of pathogenic bacteria in situ and the
effect of clinical or experimental drugs on the entire host−
pathogen system. By combining fluorescent protein expression,
proteome and cell wall labeling with high-content CLEM and
flow cytometry, we were able to obtain new information about
the complex intracellular behavior of Mtb in macrophages.
CLEM allows for simple fluorescence-guided detection of
bacterial structures, and inversely, EM-guided analysis of
fluorescent labels. The ultrastructural information on EM
provides a subcellular description of both the bacterial
behavior and that of the host cell. In addition, flow cytometry
provides a quantification method for bacterial label retention
under varying conditions. Using a triple labeling strategy,
different components of the bacterium could be visualized,
providing multiparameter information about the metabolic
state of the pathogen, although the sought-after in vivo
unambigious identification of live, dormant, and dead bacteria
remains beyond our grasp. Using multiple labels also
significantly reduces the chance of missing events due to
absence of a fluorescent label and, at the minimum, provides
an internal standard for equivalent labels (Aha and alkDala).
Alternatively, using a single bioorthogonal label could bypass
the arduous task of genetically labeling a complicated level-3
pathogen, like Mtb.
We observed large differences between intracellular
distribution of Mtb under normal conditions versus treatment
with various clinical antibiotics. Rifampicin displayed the
clearest effect on distribution, while isoniazid and ethambutol
only had a mild effect. These observations suggest a more
direct effect of rifampicin on bacterial pathogenicity and/or
viability, which is in agreement with its proposed mechanism
of action.71 Surprisingly, a routine low dose of gentamicin
displayed a strong effect on distribution, which was additive to
both untreated cells or cells treated with all three antibiotics
simultaneously. We hypothesized that this was due to bacteria
escaping from the host cell, undergoing gentamicin-induced
extracellular killing, followed by reinternalization by surround-
ing macrophages. Although this effect is unlikely to interfere
with routine readouts, due to its additive nature, we caution
others to consider a potential bias on drug efficacy. Flow
cytometry-based quantification of label retention showed a
clear loss of label retention over time, which was almost
completely rescued by isoniazid or ethambutol treatment but
to a far lesser extent by rifampicin or the triple antibiotics
combination. Label dilution over time is expected due to
bacterial division with no additional metabolic labels present in
the medium. Label retention over time is therefore a result of
inhibition of bacterial division, which is in accordance with the
proposed mechanism of action for these antibiotics.71 Perhaps
most surprising is the apparently intermediate efficacy of the
triple antibiotic combination, both in terms of bacterial
distribution and label retention.
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Besides broadly occurring phenomena, such as the
subcellular distribution of Mtb, we observed many less
common events such as apparent phagosome-lysosome fusion,
possible autophagy of cytosolic Mtb, partially degraded Mtb
fragments, leakage, and vesicular transport of fluorescently
labeled Mtb components, bacterial lipid inclusions and
exocytosis of mycolic acids. Although these observations
could not yet be supported by sufficient evidence, they present
an interesting starting point for follow-up studies, highlighting
the exploratory power of CLEM.
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